Table 1 Baseline characteristics of study participants in the district capital and the Kwahu Government Hospital
Variable | n (%) | |
|---|---|---|
Sex | Hospital | Community |
 M | 40 (11.3) | 196 (54.4) |
 F | 314 (88.7) | 164 (45.6) |
Age group (years) | ||
 ≤5 | 23 (6.5) | 60 (16.7) |
 6–10 | 12 (3.4) | 60 (16.7) |
 11–18 | 39 (11) | 60 (16.7) |
 19–30 | 155 (43.8) | 60 (16.7) |
 31–60 | 105 (29.7) | 60 (16.7) |
 Over 60 | 20 (5.6) | 60 (16.7) |
Recent anti-malarial intake | ||
 <3 months | 29 (8.2) | 55 (15.3) |
 3–6 months | 75 (21.2) | 87 (24.2) |
 No | 250 (70.6) | 218 (60.5) |
Preventive measures | Â | |
 None | 16 (4.5) | 142 (39.4) |
 ITN | 58 (16.4) | 104 28.9) |
 Other (mosquito spray & coil) | 280 (79.1) | 114 (31.7) |
Sickling status | ||
 HbAA | 262 (74) | 276 (76.7) |
 HbAC | 41 (11.6) | 30 (8.3) |
 HbAS | 45 (12.7) | 43 (11.9) |
 HbSC | 4 (1.1) | 6 (1.7) |
 HbSS | 2 (0.6) | 5 (1.4) |
HIV status | ||
 Neg | 299 (85.6) |  |
 HIV 1 | 42 (11.9) |  |
 HIV 2 | 0 (0) |  |
 HIV 1 & 2 | 9 (2.5) |  |
Malariaa | ||
 Negative | 261 (73.7) | 317 (88.1) |
 Positive | 93 (26.3) | 43 (11.9) |
Other conditions | ||
 Diabetes | 13 (3.7) |  |
 Pregnancy | 94 (26.6) |  |